Your browser doesn't support javascript.
loading
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Iveson, Timothy J; Kerr, Rachel S; Saunders, Mark P; Cassidy, Jim; Hollander, Niels Henrik; Tabernero, Josep; Haydon, Andrew; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; McQueen, John; Scudder, Claire; Boyd, Kathleen Anne; Briggs, Andrew; Waterston, Ashita; Medley, Louise; Wilson, Charles; Ellis, Richard; Essapen, Sharadah; Dhadda, Amandeep S; Harrison, Mark; Falk, Stephen; Raouf, Sherif; Rees, Charlotte; Olesen, Rene K; Propper, David; Bridgewater, John; Azzabi, Ashraf; Farrugia, David; Webb, Andrew; Cunningham, David; Hickish, Tamas; Weaver, Andrew; Gollins, Simon; Wasan, Harpreet S; Paul, James.
  • Iveson TJ; Southampton University Hospital NHS Foundation Trust, Southampton, UK. Electronic address: tim.iveson@uhs.nhs.uk.
  • Kerr RS; Department of Oncology, University of Oxford, Oxford, UK.
  • Saunders MP; The Christie Hospital, Manchester, UK.
  • Cassidy J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Hollander NH; Department of Oncology and Palliative Care, Zealand University Hospital, Naestved, Denmark.
  • Tabernero J; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.
  • Haydon A; Australasian Gastro-Intestinal Trials Group, Melbourne, VIC, Australia.
  • Glimelius B; IGP, University of Uppsala, Uppsala, Sweden.
  • Harkin A; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Allan K; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • McQueen J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Scudder C; OCTO, University of Oxford, Department of Oncology, Oxford, UK.
  • Boyd KA; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Briggs A; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK; Center for Health and Policy Outcomes, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Centre, New York, NY, USA.
  • Waterston A; Beatson West of Scotland Cancer Centre, Glasgow UK.
  • Medley L; Royal United Hospital, Bath, UK.
  • Wilson C; Addenbrookes Hospital, Cambridge, UK.
  • Ellis R; Royal Cornwall Hospital NHS Trust, Truro, UK.
  • Essapen S; St Luke's Cancer Centre, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK.
  • Dhadda AS; Castle Hill Hospital, Hull, UK.
  • Harrison M; Mount Vernon Cancer Centre, Northwood, UK.
  • Falk S; Bristol Cancer Institute, Bristol, UK.
  • Raouf S; Barking Havering and Redbridge University Hospital NHS Trust, Barking, UK.
  • Rees C; Southampton University Hospital NHS Foundation Trust, Southampton, UK.
  • Olesen RK; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Propper D; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Bridgewater J; UCL Cancer Institute, University College London, London UK.
  • Azzabi A; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
  • Farrugia D; Gloucestershire Oncology Centre, Cheltenham General Hospital, Cheltenham, UK.
  • Webb A; Brighton and Sussex University Hospital Trust, Brighton, UK.
  • Cunningham D; Royal Marsden Hospital, London, UK.
  • Hickish T; Poole Hospital, Bournemouth University, Bournemouth, UK.
  • Weaver A; Department of Oncology, Oxford University Hospitals Foundation Trust, Oxford, UK.
  • Gollins S; North Wales Cancer Treatment Centre, Rhyl, UK.
  • Wasan HS; Hammersmith Hospital, Imperial College London, London, UK.
  • Paul J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Lancet Oncol ; 19(4): 562-578, 2018 04.
Article en En | MEDLINE | ID: mdl-29611518
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article